
CJC-1295 (No DAC) + Ipamorelin Blend
GHRH analog + selective secretagogue
$84.00
Size
Secure payment by card link, Zelle or crypto · discreet packaging · fast USPS shipping
In stock · ships from the USA via USPS
CJC-1295 (no DAC) 5 mg with ipamorelin 5 mg in one co-lyophilized vial (10 mg total), also offered as 10 mg + 10 mg. A 1:1 GHRH analog and selective secretagogue blend sold by V8 Peptides for laboratory research use only, shipped from the USA with a ≥98% HPLC purity specification.
Research applications
- 01Growth-hormone-axis signaling
- 02GHRH & secretagogue research
- 03Pulsatile-secretion research models
- Sizes
- 5 mg / 5 mg · 10 mg / 10 mg
- Purity
- ≥98%
- Sequence / identity
- Reported on the certificate of analysis, where published
- Supplied form
- Lyophilized powder
- Storage
- Refrigerate at 2–8 °C; −20 °C for long-term. Protect from heat, moisture & light.
- Container
- Sealed clear glass research vial
- ✓Compound identity & sequence
- ✓Measured purity (HPLC %)
- ✓Sequence / identity confirmation
- ✓Batch / lot number
- ✓Analytical test date
- ✓Supplied form & storage
Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.
Batch documentation
Batch-specific analytical documentation supports receiving, verification, and internal recordkeeping.
Storage guidance
Refrigerate the supplied material, freeze for long-term storage, and protect it from heat, moisture, and light.
Research-only labeling
Every vial is clearly identified for laboratory research use only — not for human or veterinary use.
CJC-1295 (no DAC) + ipamorelin blend: two growth-hormone-axis research peptides co-lyophilized 1:1 by mass in one sealed glass vial, in 5 mg / 5 mg and 10 mg / 10 mg sizes, specified at ≥98% purity by HPLC. Sold for laboratory research use only and shipped within the United States. Looking for the single peptide? See CJC-1295 (No DAC) on its own.
What Is the CJC-1295 (No DAC) + Ipamorelin Blend?
This product pairs two growth-hormone-axis research peptides in one co-lyophilized vial at a 1:1 mass ratio. It is available in two sizes: 5 mg of each peptide (10 mg total) or 10 mg of each (20 mg total).
The blend is often written in shorthand as CJC/Ipa or “CJC no DAC + Ipa”. These names refer to the same two-peptide combination.
CJC-1295 without DAC, also called modified GRF (1-29), is a 29-amino-acid analog of growth-hormone-releasing hormone (GHRH). Four amino-acid substitutions make it more resistant to enzymatic cleavage than native GRF (1-29). "No DAC" means the peptide lacks the drug affinity complex, the albumin-binding group found on the DAC version, so its activity window in research models is short and pulse-like. It acts at the GHRH receptor on pituitary somatotrophs.
Ipamorelin is a synthetic pentapeptide and a selective agonist of the ghrelin receptor (GHS-R1a). It is valued in endocrine research because it stimulates the growth-hormone axis with little effect on ACTH or cortisol in published animal work. Since the two peptides act through different receptors, the blend is used to study GHRH and secretagogue signaling together and to model pulsatile secretion.
Blend Specifications
| Contents | CJC-1295 (No DAC) + Ipamorelin, 1:1 |
|---|---|
| Vial sizes | 5 mg / 5 mg · 10 mg / 10 mg |
| Purity | ≥98% by HPLC |
| Receptor targets | GHRH receptor; ghrelin receptor (GHS-R1a) |
| Identity | Sequence confirmation reported on the batch COA |
| Form | Co-lyophilized powder, sealed clear glass vial |
| Storage | 2–8 °C short term; −20 °C long term |
Reconstitution & Storage for Research
In a 1:1 blend each peptide is at the same mass concentration, and the total is double that figure. Check the vial size first, because the same diluent volume produces different results in the two sizes.
Concentration math
- Adding 2 mL of diluent to the 5 mg / 5 mg vial gives 2.5 mg/mL of each peptide (5 mg/mL total).
- Adding 1 mL of diluent to the 5 mg / 5 mg vial gives 5 mg/mL of each peptide (10 mg/mL total).
- Adding 2 mL of diluent to the 10 mg / 10 mg vial gives 5 mg/mL of each peptide (10 mg/mL total).
Equal mass does not mean equal molarity: ipamorelin is a much smaller molecule than CJC-1295, so a 1:1 blend by mass contains several times more ipamorelin molecules. If your assay is designed in molar terms, convert using the molar mass of each peptide. The calculator covers the mg/mL step. Dissolve the cake by adding diluent against the vial wall and swirling gently.
Storage conditions
Refrigerate sealed vials at 2–8 °C and freeze at −20 °C for long-term storage, protected from heat, moisture and light. Keep reconstituted solution cold and aliquot it; short GHRH analogs lose integrity with repeated temperature cycling. Further guidance is in CJC-1295 + ipamorelin reconstitution and storage.
Quality & Testing
Both vial sizes are produced to the same specification. Both sizes are specified at ≥98% purity by HPLC.
- HPLC purity for the batch
- Identity and sequence confirmation
- Lot number and test date
- Supplied form and storage statement
No lab report is published for this blend yet; reports appear on the COA page as they come back. For the analytical background, see CJC-1295 + ipamorelin purity testing.
Mechanism and Research Use
The two components act at different receptors. CJC-1295 without DAC (modified GRF 1-29, average molar mass about 3,368 g/mol) activates the GHRH receptor on pituitary somatotrophs. Ipamorelin (the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, about 712 g/mol) releases growth hormone through the ghrelin receptor; in the original pharmacology it did not raise ACTH or cortisol in swine, even at doses more than 200-fold above the GH ED50 (reference 1).
Because the 1:1 mass ratio and the molar masses differ, a vial contains about 4.7 times more ipamorelin molecules than CJC-1295 molecules (3,368 ÷ 712). Use molar amounts, not mass, when an assay compares the two.
- Co-stimulation of the GHRH and ghrelin receptors in pituitary cell cultures
- Pulsatile versus sustained GH-axis signaling models; the no-DAC form has a short activity window, unlike the DAC form (see CJC-1295 with DAC vs. without DAC)
- Blend-versus-separate-vial comparisons, see blend vs. separate vials
- HPLC method development for two-peptide mixtures
Shipping, Handling & Returns
Vials are produced in South Carolina and shipped from Florida to addresses in the United States only. Each vial travels sealed in its original glass container. If an order arrives damaged or incorrect, contact us within 48 hours of delivery and we will arrange a replacement or a refund to the original payment method. Questions go to the support address in the site footer.
CJC-1295 + Ipamorelin Research FAQ
What is the difference between CJC-1295 with DAC and without DAC?
The DAC version carries an albumin-binding group that extends its time in circulation in published work. “No DAC” (also called Mod GRF 1-29 or tetrasubstituted GRF 1-29) lacks that group, so its activity is short and pulse-like. This product uses the no-DAC form.
What sizes does the blend come in and what is the ratio?
5 mg CJC-1295 (no DAC) + 5 mg ipamorelin (10 mg total) or 10 mg + 10 mg (20 mg total). The ratio is 1:1 by mass in both sizes.
How do I make a stock solution from the vial?
Divide the amount of each peptide by the solvent volume. For the 5 mg / 5 mg vial, 2 mL gives 2.5 mg/mL of each peptide. The reconstitution calculator handles other volumes and the reconstitution and storage guide covers technique.
How do I verify purity?
The release specification is ≥98% purity by HPLC. Certificates from the independent lab Accumark Labs are published for tested lots on the COA page as reports come back; contact us for the status of a specific lot.
How should the blend be stored?
Keep sealed vials at 2–8 °C short term or −20 °C long term, away from heat, moisture and light. Aliquot reconstituted solution and keep it cold.
Do you ship outside the United States?
No. Orders ship from Florida to United States addresses only. A damaged or incorrect order is replaced or refunded to the original payment method.
References
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PubMed 9849822
Related Lab Guides
- CJC-1295 and ipamorelin: how the research blend works
- CJC-1295 + ipamorelin research overview
- CJC-1295 + ipamorelin mechanism of action
- Reconstitution and storage notes
- CJC-1295 vs. ipamorelin
- Where to buy CJC-1295 + ipamorelin
- Reconstitution calculator guide
- CJC-1295 and Ipamorelin Animal Studies: Methods Guide
- CJC-1295 + Ipamorelin Blend: Molar Ratio Math
- CJC-1295 Ipamorelin Blend: Lab Planning Guide
- CJC-1295 Ipamorelin Blend Shelf Life and Stability
- CJC-1295 Ipamorelin Blend or Separate Vials?
- CJC-1295 + Ipamorelin: Testing Additivity and Synergy
- CJC-1295 + Ipamorelin Research Stack: Evidence Map
For laboratory research use only; not for human consumption.
Quick Answers
What purity is CJC-1295 (No DAC) + Ipamorelin Blend?+
CJC-1295 (No DAC) + Ipamorelin Blend is specified at ≥98% purity by HPLC. A certificate of analysis for this product is not published on our site yet; see the COA page for the reports that are available.
How is CJC-1295 (No DAC) + Ipamorelin Blend supplied and stored?+
CJC-1295 (No DAC) + Ipamorelin Blend is supplied as a lyophilized powder. Refrigerate at 2–8 °C, or freeze at −20 °C for long-term storage. Protect from heat, moisture, and light.
Do you provide a Certificate of Analysis?+
Certificates of Analysis from our independent lab are published for tested lots (see the COA page), and we add more as reports come back. Contact us for the status of a specific product or lot.
Is CJC-1295 (No DAC) + Ipamorelin Blend approved for human use?+
No. This product is sold strictly for laboratory research and development purposes and is not for human or animal consumption.





